About this trial
The goal of this clinical trial is to compare time of sedation between two drugs administered to patients undergoing upper gastrointestinal endoscopy Primary outcome : Time of sedation : is the time to reach sedation score of 5 according to modified Ramsay sedation score starting from the time of injecting bolts dose of study drugs
Secondary outcome :
* Recovery time :is the time to reach score 2 of modified Ramsay sedation score starting from injecting bolus dose of study drugs . * Hemodynamics (MAP,HR) \& oxygen saturation * Drug side effects (nausea,vomitting,agitation) * Endoscopist satisfaction
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient acceptance
Adults aged 21-60 years.
Both sexes
BMI<35 kg/m2
Disqualifiers
• Known allergy to any of the study drugs
Unstable Cardiovascular disease
Moderate to severe respiratory diseases
Trial population
Adult patients not more than 60 years old with BMI \< 35 kg/m2
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Comparison between time of sedation between ketamine Dexametomidine and propofol midazolam in sedation of GI endoscopy
Time of sedation :is the time to reach sedation score of 5 according to modified Ramsay sedation score starting from the time of injecting bolts dose of study drugs
Comparison time of sedation between ketamine Dexametomidine and propofol midazolam in sedation of GI endoscopy
Time of sedation:is the time to reach sedation score of 5 according to modified Ramsay sedation score starting from the time of injecting bolts dose of study drugs
Comparison of time of sedation between ketamine Dexametomidine g
• Time of sedation :is the time to reach score 5 of modified Ramsay sedation score starting from injecting bolus dose of study drugs .
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: